USANA Health Sciences (USNA) Cash Flow Statement

Click line-items for a historical chart and %

Net earnings	78.16M
Depreciation and amortization	9.93M
Loss on sale of property and equipment	55K
Equity-based compensation expense	13.96M
Excess tax benefits from equity-based payment arrangements	0
Deferred income taxes	-2.25M
Inventory valuation
Inventories	-7.92M
Prepaid expenses and other assets	-12.18M
Accounts payable	597K
Other liabilities	1.39M
Total adjustments
Net cash provided by operating activities
Proceeds from sale of property and equipment	3K
Purchases of property and equipment	-26.05M
Net cash used in investing activities
Proceeds from equity awards exercised
Excess tax benefits from equity-based payment arrangements	0
Repurchase of common stock	-64.61M
Payments on line of credit	-72.5M
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents	-1.3M
Net increase in cash and cash equivalents	-8.67M
Cash and cash equivalents, beginning of period	143.21M
Cash and cash equivalents, end of period	134.54M
Interest	317K
Income taxes	41.11M

Entities mentioned with USNA

View All Entities